Who's To Blame For The High Cost Of Cancer Care (The Federal Government Or Justin Bieber?)
Although cancer care is increasingly becoming hospital or health system based, merger mania in oncology is probably not driven primarily as a way for hospitals to gain access to discounted drugs. Broader forces are at play.
Listen to part two of the episode recorded live on location at HealtheVoices 2018. (Part one was posted last week, so check it out if you haven’t, already.) In this continuation of the multi-advocate panel discussion, our panelists talk about the most difficult aspect of their advocacy and how they deal with it. They also address misconceptions and ignorance about their diseases, such as the difference between AIDS and HIV or IBD and IBS, the fact that lupus is not contagious, and that men can have breast cancer. To close out the episode, each panelist shares his/her thoughts on what advocates for different condition...
New research provides further promising evidence that molecular approaches might slow or reverse the progress of glioblastoma, an aggressive brain cancer.
Listen to part one of the first ever LIVE Psych Central Show, recorded on location at HealtheVoices 2018, an annual event that brings together online advocates from across various health conditions for an opportunity to learn, share and connect. In this show, you will meet four advocates who join our hosts on stage for a panel discussion on a variety of advocacy issues, including lupus, inflammatory bowel disease, HIV, and breast cancer. You’ll hear about how being diagnosed affected their lives in ways they didn’t expect, and what made them become advocates. The second half of this show will be posted next wee...
The objective of this article is to summarize the current body of evidence describing NCS-1 and its interactions on a molecular and cellular scale, as well as describing macroscopic implications in physiology and medicine. Particular attention is paid to the role of NCS-1 in development and prevention of chemotherapy induced peripheral neuropathy (CIPN).
Conditions: Castration-resistant Prostate Cancer; Homologous Recombination Deficiency Intervention: Drug: Testosterone Enanthate Sponsor: St Vincent's Hospital, Sydney Not yet recruiting
The objective of this article is to summarize the current body of evidence describing NCS-1 and its interactions on a molecular and cellular scale, as well as describing macroscopic implications in physiology and medicine. Particular attention is paid to the role of NCS-1 in development and prevention of chemotherapy induced peripheral neuropathy (CIPN). PMID: 29746899 [PubMed - as supplied by publisher]
Abstract Mood disorders comprise major depressive disorder (MDD), bipolar disorder (BD) and the milder forms of these two disorders. Reccurring MDD is also known as unipolar disorder. The distinction between unipolar and bipolar disorders was first suggested in 1957 by Leonard and was made official after support by several studies in 1980. Indeed, in 150 AD, Aretaeus of Cappadocia wrote "It seems to me that melancholia is the beginning and a part of mania". Additionally, Kraepelin, who proposed the first medical disease model in psychiatry a century ago, considered recurrent unipolar depression cases und...